NEW YORK (GenomeWeb News) – Phalanx Biotech Group has licensed Rosetta Biosoftware's Resolver system for use in its high-throughput gene expression and miRNA profiling services.

Rosetta said that its software system will enable the Taiwan-based microarray and genomics services firm to meet data management and analysis requirements associated with high sample volumes and will facilitate collaboration and results sharing between Phalanx and its customers.

Financial terms of the license were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.

Mar
13
Sponsored by
Agilent

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.